Reuters logo
BRIEF-Acadia Pharmaceuticals reports Q1 revenue $15.3 million
May 9, 2017 / 9:04 PM / 4 months ago

BRIEF-Acadia Pharmaceuticals reports Q1 revenue $15.3 million

May 9 (Reuters) - Acadia Pharmaceuticals Inc

* Acadia Pharmaceuticals reports first quarter 2017 financial results

* Q1 revenue $15.3 million versus I/B/E/S view $15.2 million

* Q1 loss per share $0.72

* Q1 earnings per share view $-0.73 -- Thomson Reuters I/B/E/S

* Acadia Pharmaceuticals Inc says plan to advance Alzheimer’s disease psychosis (ad psychosis) program into phase III in second half of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below